Professor Oliver Bathe examines how a new molecular test can lead to smarter decisions and better patient care outcomes in ...
Ribosomes are the cell's protein factories, which read the genetic code and assemble the proteins that every organism needs to live. But as far as how ribosomes themselves were formed, tantalizingly ...
Equitable access to genomic testing for NSCLC patients is vital for advanced therapy access, with strategies including commercial contracts and financial assistance programs. Financial toxicity and ...
Stomach cancer is challenging to detect early due to vague symptoms, often diagnosed at advanced stages. Diagnosis involves ...
The Las Vegas Medical District is set to expand with a new testing facility that officials say will strengthen the region’s ...
Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...
Bent bone dysplasia (BBD) is a perinatal-lethal skeletal disorder caused by pathogenic FGFR2 mutations that disrupt bone ...
Innovative cancer therapies are transforming treatment landscapes, yet access challenges persist. Experts discuss strategies ...
The FDA has granted breakthrough therapy designation to zenocutuzumab (Bizengri) for the treatment of patients with advanced ...
A label-free nanopore platform uses programmable DNA circuits to build versatile molecular logic gates, forming a universal basis for scalable DNA computing and advanced biosensing applications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback